Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research | News
Search Refinements

Contract Research News

View news from other Pharmaceutical sectors:
16-30 of 2107 results
Oxford BioMedica partners with Orchard Therapeutics
Gene and cell therapy firm Oxford BioMedica has partnered with Orchard Therapeutics, a clinical-stage biotechnology firm dedicated to bringing transformative ex-vivo gene therapies to patients with severe and life-threatening orphan diseases.
Contract Research & Services > Contract Research > News
GeoVax, ViaMune to partner on cancer immunotherapy program
GeoVax Labs and ViaMune are collaborating on cancer immunotherapy programs.
Contract Research & Services > Contract Research > News
Cannabis Science to start in-house clinical research with IGXBio's immunotherapy
Cannabis Science said its in-house lab is almost complete and has started clinical development plans to start working with its partner IGXBio to develop effective cannabinoid therapeutics using IGXBio's Immunotherapy (GenePro, also referred to as Δ4SHIVKU2) FDA Investigational New Drug (IND) Number 015982.
Contract Research & Services > Contract Research > News
IFM Therapeutics establishes German subsidiary and research site in Bonn
IFM Therapeutics has established a German subsidiary, IFM Therapeutics, and a research site at the Institute of Innate Immunity within the University of Bonn.
Contract Research & Services > Contract Research > News
Oasmia enters into collaboration deal with Karo Pharma for cancer project
Oasmia Pharmaceutical and Karo Pharma have signed an agreement concerning Karo Pharma’s cancer project KB9520, which has demonstrated promising results in pre-clinical models for several types of cancer.
Contract Research & Services > Contract Research > News
EnGenelC enters into research collaboration with Takeda
EnGeneIC has entered into a research collaboration with, and granted an exclusive licence option to, Takeda Pharmaceutical Company to develop its EDV nanocell platform for targeted cyto-immunotherapy in cancer.
Contract Research & Services > Contract Research > News
Synthetic Biologics wins research contract from US CDC
Synthetic Biologics has secured a contract from the Centers for Disease Control and Prevention (CDC) for microbiome assessment and intervention to address antibiotic resistance.
Contract Research & Services > Contract Research > News
Daiichi Sankyo enters into immuno-oncology research collaboration with AgonOx
Daiichi Sankyo has entered into a strategic collaboration with AgonOx, a privately held biotechnology firm developing a pipeline of novel immunotherapy drugs targeting key regulators of the immune response to cancer, to develop an undisclosed immuno-oncology target.
Contract Research & Services > Contract Research > News
Catabasis, Sarepta partner to explore combination drug for Duchenne muscular dystrophy
Catabasis Pharmaceuticals and Sarepta Therapeutics have announced a joint research collaboration to explore a combination drug treatment approach for Duchenne muscular dystrophy (DMD).
Contract Research & Services > Contract Research > News
Oncodesign to buy GSK's French research center
Oncodesign has agreed to acquire the François Hyafil Research Centre located in Villebon-sur-Yvette (Essonne) from GSK, part of the Paris Saclay innovation cluster, including transfer of the team of highly qualified drug discovery staff located at the site (anticipated to be 57 employees).
Contract Research & Services > Contract Research > News
Bristol-Myers to test Opdivo with Nektar Therapeutics drug in five tumor types
By PBR Staff Writer
Bristol-Myers Squibb (BMS) is evaluating the use of its cancer immunotherapy, Opdivo, in combination with an experimental drug from Nektar Therapeutics to treat several cancers.
Contract Research & Services > Contract Research > News
Evotec forms research collaboration with Inserm Transfert in oncology
Evotec has entered into a research collaboration with Inserm Transfert, the private subsidiary of the French National Institute of Health and Medical Research (Inserm).
Contract Research & Services > Contract Research > News
Takeda, Affilogic partner to develop CNS therapies
Takeda Pharmaceutical Company and Affilogic have entered into a research collaboration to explore using Affilogic’s Nanofitins platform in therapies targeting the central nervous system (CNS).
Contract Research & Services > Contract Research > News
Bayer, Evotec join hands to develop new treatments for kidney diseases
By PBR Staff Writer
Bayer and German firm Evotec have partnered to develop to new treatments for kidney diseases.
Contract Research & Services > Contract Research > News
Redx Pharma confirms potential role for Porcupine inhibitor in cancer immunotherapy
Redx Pharma has confirmed that its lead cancer treatment, the Porcupine inhibitor (RXC004), has a potential role in cancer immunotherapy.
Contract Research & Services > Contract Research > News
16-30 of 2107 results